Skip to main content
Download PDF

Volume 3 Supplement 2

30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015)

Semaphorin 4D produced by human head and neck squamous cell carcinoma induces myeloid derived suppressor cells expansion from peripheral blood monocytes

Journal for ImmunoTherapy of Cancer volume 3, Article number: P280 (2015) Cite this article

Background

Immune suppression is one of the hallmarks by which head and neck squamous cell carcinoma (HNSCC) develops a tumor permissible environment[1]. Semaphorin 4D (Sema4D), known for its various developmental, physiological and pathological effects, was recently shown to play a role in regulating the immune system[2]. Sema4D is expressed in many epithelial tumors including HNSCC[3]; yet, the effect of Sema4D on modulating the inflammatory profile within the tumor microenvironment of HNSCC remains to be elucidated.

Methods

Human HNSCC cell lines HN6 and HN13 were used to study the effect of Sema4D produced in tumor conditioned media (TCM), on myeloid and T cells separated from human peripheral blood mononuclear cells (PBMC) of healthy donors. Neutralizing anti-Sema4D antibody and Sema4D immune depletion from the TCM were carried out. Lentivirus shRNA was also used to knock down Sema4D in HNSCC-HN6 cells.

Results

Treatment of PBMC with TCM from HNSCC HN6 and HN13 cell lines resulted in a significant induction in myeloid derived suppressor cells (MDSC; CD33+ CD11b+ HLA-DR-/low) from freshly isolated CD33+ cells. This increase in MDSC corresponded with the suppression of autologous T cell proliferation and a reduction in IFN-γ production. Blockade of Sema4D in the TCM of HN6 and HN13 using anti-Sema4D antibody resulted in a significant reduction in the MDSC population. Furthermore, TCM from HN6 Sema4D-shRNA rescued the MDSC-mediated T cell suppression and recovered IFN-γ, compared to the control. Analysis of the recovered T cell population showed an increase in the effector T cell population (CD4+Tbet+ and CD8+Tbet+), and a decrease in regulatory T cells (CD4+CD25+FoxP3+). Mechanistically, we found a decrease in arginase-1 produced by myeloid cells cultured in HN6 Sema4D-shRNA TCM, as well as a reduction in the immune suppressive cytokines, TGF-β, and IL-10.

Conclusion

This study describes a novel immunosuppressive mechanism for HNSCC through Sema4D induction of MDSCs. Collectively; our work highlights the therapeutic potential of Sema4D inhibition as a strategy to improve the efficacy of immunotherapy in HNSCC.

References

  1. Gildener-Leapman N, Ferris RL, Bauman JE: Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncol. 2013, 49 (12): 1089-1096.

    Article  PubMed  Google Scholar 

  2. Bismuth G, Boumsell L: Controlling the immune system through semaphorins. Sci STKE. 2002, 2002 (128): re4-

    Article  PubMed  Google Scholar 

  3. Basile JR, Castilho RM, Williams VP, Gutkind JS: Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci. 2006, 103 (24): 9017-9022.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Dentistry, University of Maryland Baltimore, Baltimore, MD, USA

    Rania H Younis & Kyu Lee Han

  2. School of Medicine, University of Maryland Baltimore, Baltimore, MD, USA

    Tonya Webb

Authors
  1. Rania H Younis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyu Lee Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tonya Webb
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Younis, R.H., Han, K.L. & Webb, T. Semaphorin 4D produced by human head and neck squamous cell carcinoma induces myeloid derived suppressor cells expansion from peripheral blood monocytes. j. immunotherapy cancer 3 (Suppl 2), P280 (2015). https://doi.org/10.1186/2051-1426-3-S2-P280

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2051-1426-3-S2-P280

Keywords

  • Peripheral Blood Mononuclear Cell
  • Neck Squamous Cell Carcinoma
  • Human Peripheral Blood Mononuclear Cell
  • Myeloid Derive Suppressor Cell
  • HN13 Cell